127 related articles for article (PubMed ID: 25776995)
1. Outcome after surgical resection for duodenal adenocarcinoma in the UK.
Solaini L; Jamieson NB; Metcalfe M; Abu Hilal M; Soonawalla Z; Davidson BR; McKay C; Kocher HM;
Br J Surg; 2015 May; 102(6):676-81. PubMed ID: 25776995
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
[No Abstract] [Full Text] [Related]
4. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom.
Lee CHA; Shingler G; Mowbray NG; Al-Sarireh B; Evans P; Smith M; Usatoff V; Pilgrim C
ANZ J Surg; 2018 Mar; 88(3):E157-E161. PubMed ID: 28122405
[TBL] [Abstract][Full Text] [Related]
5. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
6. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
Rose DM; Hochwald SN; Klimstra DS; Brennan MF
J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
Bucher P; Gervaz P; Morel P
Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review.
Li D; Si X; Wan T; Zhou Y
Asian J Surg; 2019 Jan; 42(1):46-52. PubMed ID: 29802028
[TBL] [Abstract][Full Text] [Related]
10. What prognostic factors are important in duodenal adenocarcinoma?
Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
[TBL] [Abstract][Full Text] [Related]
11. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.
Santoro E; Sacchi M; Scutari F; Carboni F; Graziano F
Hepatogastroenterology; 1997; 44(16):1157-63. PubMed ID: 9261617
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research.
Rotman N; Pezet D; Fagniez PL; Cherqui D; Celicout B; Lointier P
Br J Surg; 1994 Jan; 81(1):83-5. PubMed ID: 7508805
[TBL] [Abstract][Full Text] [Related]
13. Prognostic characteristics of duodenal gastrointestinal stromal tumours.
Zhang Q; Shou CH; Yu JR; Yang WL; Liu XS; Yu H; Gao Y; Shen QY; Zhao ZC
Br J Surg; 2015 Jul; 102(8):959-64. PubMed ID: 25980461
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.
Malleo G; Tonsi A; Marchegiani G; Casarotto A; Paiella S; Butturini G; Salvia R; Bassi C
Langenbecks Arch Surg; 2013 Feb; 398(2):287-94. PubMed ID: 22801737
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of primary duodenal adenocarcinoma.
Hu JX; Miao XY; Zhong DW; Dai WD; Liu W; Hu W
Hepatogastroenterology; 2006; 53(72):858-62. PubMed ID: 17153441
[TBL] [Abstract][Full Text] [Related]
16. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection?
Hurtuk MG; Devata S; Brown KM; Oshima K; Aranha GV; Pickleman J; Shoup M
Am J Surg; 2007 Mar; 193(3):319-24; discussion 324-5. PubMed ID: 17320527
[TBL] [Abstract][Full Text] [Related]
17. Extent of resection in the management of duodenal adenocarcinoma.
Kaklamanos IG; Bathe OF; Franceschi D; Camarda C; Levi J; Livingstone AS
Am J Surg; 2000 Jan; 179(1):37-41. PubMed ID: 10737576
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
19. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
Storkholm JH; Hansen CP
Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
